Literature DB >> 7274266

Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation.

J P Boissel, E Wolf, J Gillet, A Soubrane, A Cavallaro, G Mazoyer, J P Delahaye.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7274266     DOI: 10.1093/oxfordjournals.eurheartj.a061163

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Comparison of two long-acting forms of quinidine.

Authors:  A Leizorovicz; C Piolat; J P Boissel; B Sanchini; S Ferry
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Efficacy of disopyramide in conversion and prophylaxis of post-thyrotoxic atrial fibrillation.

Authors:  H Nakazawa; N Ishikawa; J Noh; T Sugimoto; M Yoshimoto; T Yashiro; O Ozaki; K Ito
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation.

Authors:  G Nichol; F McAlister; B Pham; A Laupacis; B Shea; M Green; A Tang; G Wells
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

4.  Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.

Authors:  Bernhard Schwaab; Alexander Katalinic; Uta Maria Böge; Jürgen Loh; Peter Blank; Tatjana Kölzow; Dirk Poppe; Hendrik Bonnemeier
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

Review 5.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

6.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.